Abbott Joins Forces with U.S. Department of Defense to Develop Portable Blood Tests for Evaluating Concussions

Abbott and the United States Department of Defense today announced a collaboration with the intent to develop portable blood tests to help evaluate potential concussions, also called mild traumatic brain injuries (TBIs). As part of a multi–phased approach, the tests would be developed for Abbott’s i–STAT® System, a handheld, diagnostic analyzer that is currently used for other point-of-care testing, including among military service members.

Continue reading

Chicago MedTech company, ADM Diagnostics, will change the course of Alzheimer’s research


If you have been reading my posts you have undoubtedly seen a number of articles on failed launches and the challenges facing Alzheimer’s research and clinical trials. Since 2002, 99.6% of Alzheimer’s drug candidates have failed in clinical trails. Meanwhile the prevalence of Alzheimers continues to grow as our society ages. Every 67 seconds, someone in the US developed Alzheimer’s, it is the 6th leading cause of death in the US.

Continue reading

From John: Local AdvaMed Company Features

AdvaMed, the Medtech Conference, is only a few weeks away. On October 6-8th at the McCormick Center the world of Medtech is coming to Chicago. This is the first time the conference has come to the midwest, and from everything I have heard, we are on track to make this a record conference. The AdvaMed conference is a great opportunity for us to showcase our local Medtech community. Leading up to the conference I will have a weekly featuring of a local Medtech company here in Chicago, starting today.

 1. ADM Diagnostics 

The 3 Rules in Medical Technology


Recent changes in the US health care ecosystem are having a profound and transformational impact on the medical technology industry. The Affordable Care Act has catalyzed changes in how med tech customers define value and which stakeholders are involved in decision making. While it has historically been a jewel of American manufacturing—one of the few domestic manufacturing industries that is a net exporter—med tech faces challenges to the legacy business models and strategic choices that these companies have used to excel in the past. More than ever, success requires a clear and consistent focus on delivering differentiated value and performance to customers.

Continue reading

Illinois Based Medline Industries Announces Medtech Innovation Challenge


Medical and surgical supply distributor Medline Industries Inc. may be more than 100 years old, but it was originally started by entrepreneur A.L. Mills selling aprons to butchers in the stockyards of Chicago in 1910 before pivoting to operating gowns a few years later. It has grown into a $5.8 billion family business selling wheelchairs and canes, and hospital apparel. But like many companies in healthcare, it’s faced with the challenge of how to continue to make itself relevant at a time when healthcare reform is changing how companies do business.

Continue reading

Medtech M&A shows growth in first half of 2014


Over the past 18 months, merger and acquisition (M&A) activity has accelerated in the U.S. That trend is poised to continue, if not increase, according to the first annual Deloitte M&A Trends report.

Of the 2,500 corporate and private equity respondents to Deloitte’s M&A survey, 84 percent of corporate executives anticipate a sustained, if not accelerated, pace of M&A activity in the next 24 months. The vast majority of private equity executives (89 percent) are expecting average to high deal activity going forward.

Continue reading

MATTER announces Steven Collens and Pat Flavin to senior leadership and launches membership


MATTER, the new entrepreneurship and innovation hub for next-generation health IT, medical device and biopharma companies, today announced that Steven Collens has been named the center’s chief executive officer. Pat Flavin has been named executive director, partnerships. Check out the video of the conference.

Continue reading

Madison Company gets FDA for Novel Colorectal Cancer Test

Exact Sciences Corp. announced today that the U.S. Food and Drug Administration (FDA) has approved Cologuard, the company’s noninvasive, stool DNA colorectal cancer screening test. Cologuard is the first noninvasive screening test for colorectal cancer that analyzes both stool DNA and blood biomarkers and has been proven to find 92 percent of cancers and 69 percent of the most advanced precancerous polyps in average risk patients. Cologuard, which is available through healthcare providers, offers people 50 and older at average risk for colorectal cancer an easy–to–use screening test they can do in the privacy of their own home.

Continue reading

Industry giants provide scholarships to help startups present at the AdvaMed Conference



“I get by with a little help from my friends” comes to mind as AdvaMed 2014: The MedTech Conference, announced today that industry giants Abbott, Baxter, Covidien and Johnson & Johnson provided scholarships to help startups give company presentations at the annual AdvaMed Conference.

Continue reading